...Akorn, Inc. engages in the manufacture and marketing of diagnostic and therapeutic pharmaceuticals in ophthalmology, rheumatology, anesthesia, and antidotes areas primarily in the United States. It operates through three segments: Ophthalmic, Injectable, and Contract Services. The Ophthalmic Segment manufactures and markets a line of diagnostic and therapeutic ophthalmic pharmaceutical products. Its diagnostic products include mydriatics and cycloplegics, anesthetics, topical stains, gonioscopic solutions, and angiography dyes. The segment s therapeutic products include antibiotics, anti -infectives, steroids, steroid combinations, glaucoma medications, decongestants/antihistamines, and anti -edema medications. This segment s nonpharmaceutical products include various artificial tear solutions, preservative-free lubricating ointments, eyelid cleansers, vitamin supplements, and contact lens accessories. The Injectable Segment engages in the manufacture and marketing of a line...
|
